ASCO VALUE FRAMEWORK AND ESMO MAGNITUDE OF CLINICAL BENEFIT SCALE ASSESSMENTS FOR THE IMPLEMENTATION OF NEW TECHNOLOGIES IN HEMATOLOGICAL MALIGNANCIES: CASE STUDY AND CHALLENGES IN THE PRIVATE HEALTHCARE SYSTEM

Introduction: The increasing cost of novel technologies in the oncohematology field, with increasingly flexible regulatory criteria for approval by regulatory agencies, has raised concerns among private Health Technology Assessment (HTA) bodies. The ASCO framework and ESMO-MCBS-H are validated tools...

Descrizione completa

Dettagli Bibliografici

Autori principali:	RR Sales, DM Oliveira, BC Silva, JVP Neto, EM Fagundes, RLG Cunha, MT Laloni, CG Ferreira, P Nazareth-Junior
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2024-10-01
Serie:	Hematology, Transfusion and Cell Therapy
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2531137924025495
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!